Private Trust Company’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.3K Sell
495
-174
-26% -$11.6K ﹤0.01% 1564
2026
Q1
$42K Buy
669
+444
+197% +$30.9K ﹤0.01% 1377
2025
Q4
$14.9K Sell
225
-161
-42% -$10.4K ﹤0.01% 1799
2025
Q3
$26K Sell
386
-853
-69% -$67.5K ﹤0.01% 1532
2025
Q2
$108K Buy
1,239
+567
+84% +$44.4K 0.01% 927
2025
Q1
$45.9K Buy
672
+335
+99% +$27.3K ﹤0.01% 1235
2024
Q4
$26.2K Buy
337
+245
+266% +$18.1K ﹤0.01% 1395
2024
Q3
$6.17K Sell
92
-80
-47% -$6.57K ﹤0.01% 1876
2024
Q2
$19.5K Buy
172
+102
+146% +$12.9K ﹤0.01% 1456
2024
Q1
$9.71K Sell
70
-126
-64% -$15.8K ﹤0.01% 1664
2023
Q4
$24.3K Sell
196
-589
-75% -$60.2K ﹤0.01% 1323
2023
Q3
$73.2K Sell
785
-58
-7% -$6.54K 0.01% 897
2023
Q2
$108K Buy
843
+293
+53% +$35.4K 0.01% 779
2023
Q1
$63.9K Sell
550
-11
-2% -$1.23K 0.01% 918
2022
Q4
$64K Buy
561
+144
+35% +$15.8K 0.01% 872
2022
Q3
$34K Buy
417
+29
+7% +$2.46K 0.01% 1024
2022
Q2
$29K Buy
+388
New +$35.4K ﹤0.01% 1104

Other funds holding DXCM

Private Trust Company's DXCM Position: Q2 2026 in Review

Private Trust Company reduced its DexCom (DXCM) stake by 26% in Q2 2026, selling an estimated $11.6K and leaving 495 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

Private Trust Company first reported a position in DXCM in Q2 2022 and has held it in 17 quarters since. The position peaked at $108K in Q2 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Private Trust Company held 495 shares of DexCom worth $33.3K as of Q2 2026.
  • Private Trust Company sold 174 DexCom shares in Q2 2026, an estimated $11.6K.
  • DexCom made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #1564 holding.
  • Private Trust Company first reported a position in DexCom in Q2 2022 and has held it in 17 quarters since.
  • Private Trust Company's DexCom position peaked at $108K in Q2 2023.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.